About CRESP 40MCG/ 0.4 ML
BENEFITS OF CRESP INJECTION
In Treatment of Anemia due to chronic kidney disease
Anemia is a condition where your body does not have enough red blood cells to carry oxygen around your body. Chronic kidney disease (CKD) refers to the loss of normal kidney function over a long span of time. CKD progresses gradually over a few years but may become permanent if left untreated. CKD can lead to anemia. Cresp 40 Injection can boost your levels of red blood cells and reduce the symptoms of anemia such as tiredness and weakness. Taking this injection improves the quality of life.
Show More
SIDE EFFECTS OF CRESP INJECTION
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youïre worried about them
Common side effects of Cresp
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
HOW TO USE CRESP INJECTION
Your doctor or nurse will give you this medicine. Kindly do not self administer.
HOW CRESP INJECTION WORKS
Cresp 40 Injection is an erythropoiesis-stimulating agent (ESA). It works by stimulating the bone marrow (soft tissue inside the bones which produces red blood cells) to produce more red blood cells.
Efficacy in Anemia ManagementCRESP 40MCG/0.4ML is specifically indicated for reducing anemia associated with CKD and chemotherapy. Its active ingredient, Darbepoetin Alfa, promotes red blood cell formation, improving oxygen delivery and alleviating symptoms of fatigue often experienced by anemia sufferers.
Reliable Dosing and AdministrationSupplied as a prefilled syringe with a 26G needle, CRESP 40MCG enables accurate, sterile dosing for either subcutaneous or intravenous injection. This design ensures both convenience and minimal discomfort during administration under medical supervision.
Safe Handling and StorageFor maximum efficacy, CRESP 40MCG must be stored at refrigerator temperatures (2C to 8C), protected from light, and never frozen. Proper handling helps retain stability and ensures safety from manufacture through administration.
FAQs of CRESP 40MCG/ 0.4 ML:
Q: How should CRESP 40MCG/0.4ML injection be administered?
A: CRESP 40MCG/0.4ML should be administered either subcutaneously or intravenously as directed by a physician. It is typically injected using the prefilled syringe, and the procedure should only be performed under appropriate medical supervision.
Q: What is the main benefit of using CRESP 40MCG/0.4ML for patients?
A: The primary benefit is its ability to stimulate erythropoiesis, or red blood cell formation, effectively treating anemia caused by chronic kidney disease or chemotherapy, resulting in improved energy and overall well-being.
Q: When should I use this medication, and how often should it be administered?
A: CRESP 40MCG/0.4ML should be used strictly according to the dosage and schedule prescribed by your physician. Frequency and timing depend on the specific medical condition and individual response to treatment.
Q: Where should CRESP 40MCG/0.4ML be stored before use?
A: The injection must be kept at a temperature between 2C and 8C in a refrigerator. It should always be protected from light and never be frozen to maintain its effectiveness.
Q: What precautions should be taken before using this product?
A: Before use, ensure you are not allergic to Darbepoetin Alfa. Do not use the injection if the solution appears cloudy or contains particles, and be careful not to shake the syringe before administration.
Q: Is CRESP 40MCG/0.4ML suitable for pediatric patients?
A: Yes, this medication is suitable for both adults and pediatric patients, but only when used under the guidance and supervision of a healthcare professional.